Tuberculosis-HIV co-infection

Tuberculosis is an opportunistic infection and is easily affected to the people with HIV. HIV weakens the immune system which increases chance of getting affected with tuberculosis. Person have both HIV/tuberculosis is referred as HIV-tuberculosis co-infection. Conditions become severe in the case of multi drug resistance tuberculosis and extensively drug resistance tuberculosis is difficult to cure and causes increase in mortality. Pro inflammatory cytokine production by tuberculous granulomas is connected with HIV viremia which leads to the cause of disease. Untreated latent TB infection can be easily activated to TB disease in HIV patients due to their low immunity. If not treated it leads to death. TB is difficult to diagnose in HIV positive patient than a person with only TB.HIV-TB co-infection people are treated with anti-retro viral therapy and anti-tubercular drugs. Advantages of early anti- retro viral drugs includes decreased trend of mortality


  • Immune reconstitution inflammatory syndrome.
  • Pathogenesis of co-infection of HIV and tuberculosis
  • TB reactivation by HIV
  • Animal model studies
  • HIV/TB specific T/B cell response

Related Conference of Tuberculosis-HIV co-infection

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Tuberculosis-HIV co-infection Conference Speakers

Recommended Sessions

Related Journals

Are you interested in